Cardinal Health Business Summary

Cardinal Health, Inc. (CAH) operates as a global integrated healthcare services and products provider, generating revenue primarily through high-volume, low-margin pharmaceutical and medical supply distribution. As of March 2026, the company’s business model is organized into five segments: Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution (GMPD), at-Home Solutions, Nuclear and Precision Health Solutions, and OptiFreight Logistics. The Pharmaceutical and Specialty segment is the dominant revenue driver, projected to exceed $50 billion in specialty revenue alone for fiscal 2026, supported by strategic acquisitions like Solaris Health and the Integrated Oncology Network. Cardinal Health operates within a consolidated market alongside primary competitors McKesson Corporation, Cencora, and Medline Industries; it maintains a top-tier position in the "Big Three" pharmaceutical wholesale oligopoly while differentiating through its extensive medical-surgical product manufacturing and the nation’s largest nuclear pharmacy network. Founded in 1971 by Robert D. Walter, Cardinal Health is currently led by CEO Jason Hollar, who took the helm in 2022 following his tenure as the company’s CFO and previous executive roles at Tenneco and Sears Holdings. The leadership team includes CFO Aaron Alt, formerly the CFO of Sysco, and EVP/CIO Brian Rice, who oversee a strategic pivot toward supply-chain automation and high-margin specialty services. The company’s governance is managed by an independent Board of Directors chaired by Gregory Kenny, which recently added tech-centric expertise in March 2025 with the appointments of Robert Musslewhite (former CEO of Definitive Healthcare) and Sudhakar Ramakrishna (CEO of SolarWinds). This leadership structure is currently focused on navigating the complexities of the Inflation Reduction Act and optimizing the Global Medical Products segment, which reported a 106% profit increase in Q2 fiscal 2026.